Literature DB >> 26789491

Potent μ-Opioid Receptor Agonists from Cyclic Peptides Tyr-c[D-Lys-Xxx-Tyr-Gly]: Synthesis, Biological, and Structural Evaluation.

Yangmei Li1, Margret Cazares1, Jinhua Wu1, Richard A Houghten1, Laurence Toll1, Colette Dooley1.   

Abstract

To optimize the structure of a μ-opioid receptor ligand, analogs H-Tyr-c[D-Lys-Xxx-Tyr-Gly] were synthesized and their biological activity was tested. The analog containing a Phe(3) was identified as not only exhibiting binding affinity 14-fold higher than the original hit but also producing agonist activity 3-fold more potent than morphine. NMR study suggested that a trans conformation at D-Lys(2)-Xxx(3) is crucial for these cyclic peptides to maintain high affinity, selectivity, and functional activity toward the μ-opioid receptor.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26789491     DOI: 10.1021/acs.jmedchem.5b01899

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

1.  Antinociceptive activity of thiazole-containing cyclized DAMGO and Leu-(Met) enkephalin analogs.

Authors:  Hannah M Harris; Shainnel O Eans; Michelle L Ganno; Jennifer C Davis; Colette T Dooley; Jay P McLaughlin; Adel Nefzi
Journal:  Org Biomol Chem       Date:  2019-05-16       Impact factor: 3.876

Review 2.  Cyclic Opioid Peptides.

Authors:  Michael Remesic; Yeon Sun Lee; Victor J Hruby
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

3.  Synthesis, Spatial Structure and Analgesic Activity of Sodium 3-Benzylaminocarbonyl-1-methyl-2,2-dioxo-1H-2λ⁶,1-benzothiazin-4-olate Solvates.

Authors:  Igor V Ukrainets; Lidiya A Petrushova; Svitlana V Shishkina; Lina A Grinevich; Galina Sim
Journal:  Sci Pharm       Date:  2016-10-19

4.  Cyclizing Painkillers: Development of Backbone-Cyclic TAPS Analogs.

Authors:  Alaa Talhami; Avi Swed; Shmuel Hess; Oded Ovadia; Sarit Greenberg; Adi Schumacher-Klinger; David Rosenthal; Deborah E Shalev; Mattan Hurevich; Philip Lazarovici; Amnon Hoffman; Chaim Gilon
Journal:  Front Chem       Date:  2020-11-12       Impact factor: 5.221

5.  Bis-Cyclic Guanidine Heterocyclic Peptidomimetics as Opioid Ligands with Mixed μ-, κ- and δ-Opioid Receptor Interactions: A Potential Approach to Novel Analgesics.

Authors:  Jay P McLaughlin; Ramanjaneyulu Rayala; Ashley J Bunnell; Mukund P Tantak; Shainnel O Eans; Khadija Nefzi; Michelle L Ganno; Colette T Dooley; Adel Nefzi
Journal:  Int J Mol Sci       Date:  2022-08-25       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.